{"paper_id":"0838478e-36d5-4f7d-b1da-fbebf80f7bb6","body_text":"Abstract\nEndometriosis is common benign gynecologic endometrial disorder that causes infertility and pelvic pain. Endometriosis is associated with aberrant inflammatory responses, increased production of prostaglandins, and progesterone resistance. Recently, aldo-keto reductases (1B and 1C) were shown to play an important role in metabolism of prostaglandins and progesterone. In this study, we assessed the aldo-keto reductase gene expression in endometrial cancer cells (ECC)-1 that were treated with phthalate, which has been previously shown to mediate the development of gynecological disorders. The data indicated that phthalate increased expression of aldo-keto reductases in endometrial cells and stimulated production of prostaglandins and may be involved in the development of progesterone resistance.\nSimilar content being viewed by others\nReferences\nWormuth, M., Scheringer, M., Vollenweider, M. & Hungerbühler, K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal 26:803–824 (2006).\nSwan, S. H. et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113:1056–1061 (2005).\nMartino-Andrade, A. J. & Chahoud, I. Reproductive toxicity of phthalate esters. Mol Nutr Food Res 54:148–157 (2010).\nDavis, B. J., Maronpot, R. R. & Heindel, J. J. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 128:216–223 (1994).\nLovekamp, T. N. & Davis, B. J. Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol Appl Pharmacol 172:217–224 (2001).\nLatini, G. et al. In utero exposure to di-(2-ethylhexyl) phthalate and duration of human pregnancy. Environ Health Perspect 111:1783–1785 (2003).\nCobellis, L. et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod 18:1512–1515 (2008).\nColon, I., Caro, D., Bourdony, C. J. & Rosario, O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 108:895–900 (2000).\nWallace, A. E., Gibson, D. A., Saunders, P. T. & Jabbour, H. N. Inflammatory events in endometrial adenocarcinoma. Endocrinology 206:141–157 (2010).\nPino, M. S. et al. Prostaglandin E2 drives cyclooxy-genase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells. Cancer Biol Ther 4:1263–1269 (2005).\nSales, K. J., Grant, V. & Jabbour, H. N. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol 285:51–61 (2008).\nSong, M., Kim, Y. J. & Rhew, J. C. Identification of genes induced by carbamazepine in human bronchial epithelial BEAS-2B cells. Toxicol Env Health Sci 3:106–113 (2011).\nSong, M. et al. Identification of genes induced by dibutyl phthalate in human thyroid follicular FTC-238 cells. Toxicol Env Health Sci 4:80–86 (2012).\nCho, H. H., Song, M. & Rhew, J. C. Gene expression analysis of endometrial carcinoma cells exposed to di-(2-ethylhexyl) phthalate. Mol Cell Toxicol 9:113–120 (2013).\nBeranič, N. & Lanišnik Rižner T. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line. Chem Biol Interact 202:218–225 (2013).\nJez, J. M., Flynn, T. G. & Penning, T. M. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 54:639–647 (1997).\nBrožiič, P., Turk, S., Rižner, T. L. and Gobec, S. Inhibitors of aldo-keto reductases AKR1C1-AKR1C4. Curr Med Chem 18:2554–2565 (2011).\nHenderson, B. E. & Feigelson, H. S. Hormonal carcino-genesis. Carcinogenesis 21:427–433 (2000).\nByrns, M. C. et al. Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. J. Steroid Biochem Mol Biol 118:177–187 (2010).\nByrns, M. C., Jin, Y. & Penning, T. M. Inhibitors of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights. J Steroid Biochem Mol Biol 125:95–104 (2011).\nMontgomery, R. B. et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res 68:4447–4454 (2008).\nLanišnik Rižner, T. et al. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Mol Cell Endocrinol 248:126–135 (2006).\nŠmuc, T. et al. Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol 301:59–64 (2009).\nGiudice, L. C. & Kao, L. C. Endometriosis. Lancet 364:1789–1799 (2004).\nCasey, M. L., MacDonald, P. C. & Andersson, S. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 94:2135–2141 (1994).\nDassen, H. et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 22:3148–3158 (2007).\nZeitoun, K. et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83:4474–4480 (1998).\nBeranič, N., Gobec, S. & Rižner, T. L. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3. Chem Biol Interact 191:227–233 (2011).\nRižner, T. L. Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases. Front Pharmacol 3:34 (2012).\nLumsden, M. A., Kelly, R. W. & Baird, D. T. Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha. Br J Obstet Gynaecol 90:1135–1140 (1983).\nKarck, U. et al. PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. Prostaglandins 51:49–60 (1996).\nPowell, A. M., Chan, W. Y., Alvin, P. & Litt, I. F. Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea. Prostaglandins 29:273–290 (1985).\nRicci, M. S., Toscano, D. G. & Toscano, W. A. Jr. ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function. In Vitro Cell Dev Biol Anim 35:183–189 (1999).\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nSong, JY., Cho, HH. Phthalate-treated endometrial cancer cell lines show increased AKR1C1 expression. Mol. Cell. Toxicol. 10, 379–385 (2014). https://doi.org/10.1007/s13273-014-0042-7\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s13273-014-0042-7","source_license":"CC0","license_restricted":false}